Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI and Advanced
AI analysis and Advanced tools for SHREEPAC
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
Metric
Jun-26
Mar-26
FY25-26
Revenue
4.9
5.37
21.64
Net Profit
0.76
0.97
3.02
EPS
2.04
2.67
8.31
Cash EPS
2.5
3.14
9.98
OPM %
24.85
28.53
24.06
NPM %
15.58
18.09
13.94
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m24.85
Net Profit Margin 12m15.58
Valuation
Price to Sale Ratio11.24
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
Promoter and promoter group
36.44%
Public shareholders
63.56%
Other shareholders
0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
Industry
Medical Equipment & Supplies
Sector
Healthcare
Website
www.shreepacetronix.com; www.pacetronix.com
Address
Plot No 15, Sector II, Pithampur, Dhar, Madhya Pradesh, 454775
NSE Code
SHREEPAC
BSE Code
527005
Listing date
22 Nov 1993
Face value
10
Market lot
1
CIN
L33112MP1988PLC004317
Company email
pacetronix@hotmail.com
Leadership and officers
Managing Director
Mr. Atul Kumar Sethi
Chief Operating Officer
Sumit Chakarbarti
Joint Managing Director
Mr. Akash Sethi
Chief Financial Officer
Ashok Atulkar
Non-Executive Independent Woman Director
Ms. Manali Tongia
Non-Executive Independent Woman Director
Ms. Somya Chhabra
Non-Executive - Independent Director
Mr. Chandragupt Jain
Company Secretary & Compliance Officer
Ms. Rupali Ahire
Questions
Stock FAQ
What is the symbol and ISIN of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has the symbol SHREEPAC and ISIN - INE847D01010.
What is the current price of Shree Pacetronix Ltd?
Shree Pacetronix Ltd is currently trading at INR 147.05.
What are the year high and year low of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a year high of INR 155.00 and a year low of INR 122.05.
What is the market capitalization of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a market capitalization of INR 55.10 crore.
What is the P/E ratio of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a P/E ratio of 13.64.
What is the dividend yield of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a dividend yield of NA.
How is the financial performance of Shree Pacetronix Ltd based on revenue, net income, and EPS?
Shree Pacetronix Ltd has revenue of INR 4.90 crore, net income of INR 0.76 crore, and EPS of NA.
What is the book value of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a book value of NA.
What is the debt-to-equity ratio of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Shree Pacetronix Ltd?
Shree Pacetronix Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 11.24.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.